LDL-cholesterol goal attainment under persistent lipid-lowering therapy in northeast China: Subgroup analysis of the dyslipidemia international study of China (DYSIS-China)

Lipid-lowering therapy with statins reduces the risk of cardiovascular events, but the efficacy of persistent treatment in a real-world setting may vary from regions. Routine lipid-lowering therapy in the region with a high prevalence of cardiovascular disease may lead to more failures of goal attai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wen, Zhang, Yu-Jiao, Bu, Xiang-Ting, Guo, Xin-Zhu, Hu, Da-Yi, Li, Zhan-Quan, Sun, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704808/
https://www.ncbi.nlm.nih.gov/pubmed/29145263
http://dx.doi.org/10.1097/MD.0000000000008555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704808/
https://www.ncbi.nlm.nih.gov/pubmed/29145263
http://dx.doi.org/10.1097/MD.0000000000008555

Ejemplares similares